Home › pSivida Corp. (PSDV) Upgraded to "Hold" at Zacks Investment Research
 

Keywords :   


pSivida Corp. (PSDV) Upgraded to "Hold" at Zacks Investment Research

2016-01-02 14:07:55| Biotech - Topix.net

According to Zacks, "pSivida Corp., a specialty pharmaceutical company, combines existing drugs with its sustained release delivery technologies to develop transformational products primarily in ophthalmology. pSivida's two proprietary technology systems are Durasert and Tethadur.

Tags: research hold investment corp

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Tropical Depression Thirteen-E Graphics
02.11Summary for Tropical Depression Thirteen-E (EP3/EP132024)
02.11Fragrancing Spaces with Atmos, A Smart Home Diffuser
02.11Eastern North Pacific Tropical Weather Outlook
02.11Atlantic Tropical Weather Outlook
01.11Tropical Depression Thirteen-E Forecast Discussion Number 1
01.11Tropical Depression Thirteen-E Graphics
01.11Tropical Depression Thirteen-E Wind Speed Probabilities Number 1
More »